[{"data":1,"prerenderedAt":376},["ShallowReactive",2],{"article-\u002Fresearch\u002Fcounterfeit-peptides-australia":3,"article-compounds-\u002Fresearch\u002Fcounterfeit-peptides-australia":339,"article-more-\u002Fresearch\u002Fcounterfeit-peptides-australia":362},{"id":4,"title":5,"body":6,"description":309,"extension":310,"faq":311,"meta":321,"navigation":322,"path":323,"publishedAt":324,"readingMinutes":325,"relatedCompounds":326,"seo":330,"stem":331,"tags":332,"updatedAt":337,"__hash__":338},"research\u002Fresearch\u002Fcounterfeit-peptides-australia.md","Counterfeit and Substituted Research Peptides: What Actually Gets Faked",{"type":7,"value":8,"toc":298},"minimark",[9,13,16,21,24,27,34,46,50,53,59,65,70,79,83,86,95,105,108,112,115,125,130,133,137,221,227,230,234,237,243,249,252,256,262,268,274,280,286],[10,11,12],"p",{},"\"Counterfeit\" suggests an elaborate forgery. In the research peptide market the\nreality is more mundane and harder to detect: material that is genuinely a\npeptide, genuinely a white powder, and genuinely not what was ordered.",[10,14,15],{},"There are four distinct failure modes, and they are caught by different tests.",[17,18,20],"h2",{"id":19},"_1-substitution-a-different-compound-entirely","1. Substitution: a different compound entirely",[10,22,23],{},"The vial contains a peptide. It is not the peptide on the label.",[10,25,26],{},"The economics drive this wherever price differences are large within a class of\nstructurally similar compounds. Incretin analogues are the clearest case:\nsemaglutide, tirzepatide and retatrutide are related in structure, similar in\nappearance, similar in chromatographic behaviour, and separated by substantial\ncost differences.",[10,28,29,33],{},[30,31,32],"strong",{},"Why it is hard to detect."," All lyophilised peptides look identical. A\nsubstituted compound dissolves normally, produces a clean chromatogram, and may\nwell produce an effect in an assay — just not the effect being attributed to it.\nA purity figure is entirely silent on the question, because it establishes that\nthe vial contains 99% of one thing without establishing what.",[10,35,36,39,40,45],{},[30,37,38],{},"What catches it."," Mass spectrometry. The masses in these families differ by\nhundreds of daltons, and observed-versus-theoretical mass resolves the question\nimmediately. See\n",[41,42,44],"a",{"href":43},"\u002Fresearch\u002Fmass-spectrometry-peptide-identity","what mass spectrometry establishes that HPLC cannot",".",[17,47,49],{"id":48},"_2-wrong-form-the-same-name-a-different-molecule","2. Wrong form: the same name, a different molecule",[10,51,52],{},"Less deliberate-looking than substitution and more common, because the market's\nnaming conventions permit it.",[10,54,55,58],{},[30,56,57],{},"\"TB-500\""," is used for both full-length thymosin β4 (43 residues, ~4,963 Da)\nand the Ac-LKKTETQ fragment (7 residues, ~889 Da). The fragment is a fraction of\nthe synthesis cost. Both are sold under the same name, frequently at similar\nprices.",[10,60,61,64],{},[30,62,63],{},"\"CJC-1295\""," is used for both the DAC form (~3,647 Da) and the non-DAC form\n(~3,368 Da). These behave differently in any design where duration of receptor\noccupancy matters, and a research result obtained with one does not transfer to\nthe other.",[10,66,67,69],{},[30,68,32],{}," The supplier may not be lying by their own lights —\nthe name genuinely is used both ways. The buyer receives the compound they\nordered by name and a different molecule than they intended.",[10,71,72,74,75,78],{},[30,73,38],{}," Mass spectrometry again, and the difference is not subtle.\nAlso: a certificate that states the ",[30,76,77],{},"sequence"," rather than only the trade name\nremoves the ambiguity at the point of sale.",[17,80,82],{"id":81},"_3-dilution-real-peptide-cut-with-something","3. Dilution: real peptide, cut with something",[10,84,85],{},"The vial contains the correct peptide mixed with an inert filler — mannitol,\nlactose, glycine, or simply more salt.",[10,87,88,90,91,94],{},[30,89,32],{}," This is the one that survives a superficial reading\nof a certificate best. Common fillers do not absorb UV at peptide detection\nwavelengths, so ",[30,92,93],{},"they are invisible on the chromatogram",". Material that is 50%\nmannitol by mass can return a 99% HPLC purity figure, entirely correctly, because\npurity describes the peptide-related fraction only.",[10,96,97,99,100,104],{},[30,98,38],{}," Net peptide content by amino acid analysis, which measures\nhow much peptide is actually present rather than how good the peptide fraction\nis. This is precisely the distinction covered in\n",[41,101,103],{"href":102},"\u002Fresearch\u002Fnet-peptide-content-vs-purity","net peptide content versus purity"," —\nand the reason that article matters beyond concentration arithmetic.",[10,106,107],{},"A partial check available without commissioning analysis: dissolve a known mass\nand observe. Excipient-heavy material often behaves differently — dissolving\nfaster, producing a different cake appearance, or leaving a residue.",[17,109,111],{"id":110},"_4-underfilling-the-right-material-less-of-it","4. Underfilling: the right material, less of it",[10,113,114],{},"The vial is labelled 10 mg and contains 7 mg. Nothing about the contents is\nwrong.",[10,116,117,119,120,124],{},[30,118,32],{}," This is the hardest of the four, because both\npurity and identity testing analyse a ",[121,122,123],"em",{},"sample",". Neither weighs the vial. A vial\ncontaining 7 mg of 99% pure, correctly identified peptide returns a perfect\ncertificate.",[10,126,127,129],{},[30,128,38],{}," Gravimetric verification — weighing the vial before and\nafter removing the contents, which requires an analytical balance and a\ntare-weight reference. Or quantitative analysis against a known standard, which\nmeasures how much peptide is present rather than how good it is.",[10,131,132],{},"For most buyers this is impractical, which is why it persists. The realistic\nmitigation is buying from a supplier where the fill weight is a documented\nprocess rather than an assertion.",[17,134,136],{"id":135},"what-documentation-covers","What documentation covers",[138,139,140,162],"table",{},[141,142,143],"thead",{},[144,145,146,150,153,156,159],"tr",{},[147,148,149],"th",{},"Failure mode",[147,151,152],{},"Purity (HPLC)",[147,154,155],{},"Identity (MS)",[147,157,158],{},"Net peptide content",[147,160,161],{},"Gravimetric",[163,164,165,181,194,208],"tbody",{},[144,166,167,171,174,177,179],{},[168,169,170],"td",{},"Substitution",[168,172,173],{},"✗",[168,175,176],{},"✓",[168,178,173],{},[168,180,173],{},[144,182,183,186,188,190,192],{},[168,184,185],{},"Wrong form",[168,187,173],{},[168,189,176],{},[168,191,173],{},[168,193,173],{},[144,195,196,199,201,203,205],{},[168,197,198],{},"Dilution",[168,200,173],{},[168,202,173],{},[168,204,176],{},[168,206,207],{},"partial",[144,209,210,213,215,217,219],{},[168,211,212],{},"Underfilling",[168,214,173],{},[168,216,173],{},[168,218,173],{},[168,220,176],{},[10,222,223,224],{},"The striking column is the first one. ",[30,225,226],{},"A purity percentage — the number most\nbuyers read and most vendors lead with — catches none of the four.",[10,228,229],{},"That is not an argument against purity testing, which addresses a real and\ndifferent question about synthesis quality. It is an argument against treating\npurity as the summary statistic for whether material is what it claims to be.",[17,231,233],{"id":232},"the-australian-context","The Australian context",[10,235,236],{},"Two things are specific to buying here, and they are frequently conflated.",[10,238,239,242],{},[30,240,241],{},"Domestic dispatch removes transit risk, not analytical risk."," A parcel that\ndoes not cross a border does not sit in customs, and does not spend weeks in an\nuncontrolled container. That is a genuine benefit for temperature-sensitive\nmaterial. It says nothing whatever about what is in the vial — the material was\nstill synthesised somewhere, and a domestic warehouse is a logistics fact rather\nthan a quality control.",[10,244,245,248],{},[30,246,247],{},"\"Australian\" is a claim that needs unpacking."," Australian-owned, Australian\ndispatch, Australian synthesis and Australian testing are four different claims.\nVery little research peptide synthesis happens in Australia. Analytical\nverification is frequently offshore. A supplier who blurs these together —\nimplying domestic testing because they mention domestic dispatch — is telling you\nsomething about how precisely they use language generally.",[10,250,251],{},"We dispatch from Australia. Independent verification is performed offshore. We\nkeep those separate because they are separate.",[17,253,255],{"id":254},"what-to-do","What to do",[10,257,258,261],{},[30,259,260],{},"Read the identity result, not the purity figure."," Theoretical and observed\nmass, stated as two numbers.",[10,263,264,267],{},[30,265,266],{},"Insist the certificate carries the batch number on your vial."," Without it,\nnothing on the document is evidence about your material.",[10,269,270,273],{},[30,271,272],{},"Ask for the sequence, not just the name"," — particularly for TB-500 and\nCJC-1295, where the name is genuinely ambiguous.",[10,275,276,279],{},[30,277,278],{},"Consider net peptide content"," where quantity matters, and commission it if the\nwork justifies the cost.",[10,281,282,285],{},[30,283,284],{},"Treat a purity figure as necessary and insufficient."," It answers a real\nquestion. It is not the question you were most likely to get wrong.",[10,287,288,289,293,294,45],{},"Related: ",[41,290,292],{"href":291},"\u002Fresearch\u002Fspotting-a-fabricated-coa","how to spot a fabricated COA"," and\n",[41,295,297],{"href":296},"\u002Fresearch\u002Fchoosing-a-peptide-supplier-australia","choosing a peptide supplier in Australia",{"title":299,"searchDepth":300,"depth":300,"links":301},"",2,[302,303,304,305,306,307,308],{"id":19,"depth":300,"text":20},{"id":48,"depth":300,"text":49},{"id":81,"depth":300,"text":82},{"id":110,"depth":300,"text":111},{"id":135,"depth":300,"text":136},{"id":232,"depth":300,"text":233},{"id":254,"depth":300,"text":255},"Substitution, dilution, wrong-form supply and underfilled vials — the four ways research peptides are misrepresented, why each is hard to detect, and which analytical test catches which.","md",[312,315,318],{"question":313,"answer":314},"How would I know if a research peptide was substituted?","Without analysis, you would not. Lyophilised peptides are visually indistinguishable from one another — white powder in a glass vial — and a substituted compound will dissolve, look correct and produce some effect in an assay. Mass spectrometry against theoretical mass is the practical test, which is why identity confirmation on a batch-specific certificate matters more than a purity percentage.",{"question":316,"answer":317},"Is underfilling a real problem or a theoretical one?","It is real and it is the hardest of these to detect, because the material can be entirely genuine and simply present in a smaller quantity than the label states. It is invisible to purity and identity testing, both of which analyse a sample rather than weigh the vial. Gravimetric verification or quantitative analysis against a standard is the only check.",{"question":319,"answer":320},"Does buying domestically in Australia reduce the risk?","It removes customs risk and shortens the transit chain, which matters for temperature-sensitive material. It does not by itself say anything about what is in the vial — domestic dispatch is a logistics fact, not an analytical one. The documentation is still the thing to evaluate.",{},true,"\u002Fresearch\u002Fcounterfeit-peptides-australia","2026-08-23",8,[327,328,329],"semaglutide","tb-500","cjc-1295",{"title":5,"description":309},"research\u002Fcounterfeit-peptides-australia",[333,334,335,336],"counterfeit","sourcing","quality control","Australia",null,"jGG59FyKbwzF3FILIa5I_R6xicOcWnl22bI3UatyzbU",[340,348,355],{"path":341,"name":342,"alsoKnownAs":343,"summary":344,"category":345,"molecularWeight":346,"purity":347},"\u002Fcompounds\u002Fcjc-1295","CJC-1295","Modified GRF (1-29) · CJC-1295 without DAC","A modified growth hormone-releasing hormone analogue, engineered for resistance to enzymatic cleavage while retaining a short pulsatile signal.","Growth Hormone","~3,368 Da","≥99%",{"path":349,"name":350,"alsoKnownAs":351,"summary":352,"category":353,"molecularWeight":354,"purity":347},"\u002Fcompounds\u002Fsemaglutide","Semaglutide","GLP-1 receptor agonist","A long-acting GLP-1 receptor agonist and the reference single-agonist compound in incretin research.","Metabolic","~4,114 Da",{"path":356,"name":357,"alsoKnownAs":358,"summary":359,"category":360,"molecularWeight":361,"purity":347},"\u002Fcompounds\u002Ftb-500","TB-500","Thymosin β4 · Tβ4","A synthetic form of thymosin beta-4, the principal actin-sequestering peptide in mammalian cells, studied in cell migration and tissue repair models.","Repair & Recovery","~4,963 Da",[363,367,371],{"path":296,"title":364,"description":365,"publishedAt":366},"Choosing a Research Peptide Supplier in Australia: A Checklist","Fourteen questions that separate suppliers with a real quality process from suppliers with a good website — covering documentation, testing claims, provenance, handling and the language they use.","2026-08-24",{"path":368,"title":369,"description":370,"publishedAt":324},"\u002Fresearch\u002Fresearch-peptides-australia-legal-status","Research Peptides in Australia: The Regulatory Position","How the TGA, the Poisons Standard and import rules apply to peptides supplied for laboratory research in Australia — what research-use-only means legally, and where the line sits.",{"path":372,"title":373,"description":374,"publishedAt":375},"\u002Fresearch\u002Fpeptide-aggregation-and-handling","Why Peptide Solutions Go Cloudy: Aggregation and Handling","Shaking a reconstituted peptide is the most common way to ruin one. The interfacial mechanism behind aggregation, why lipidated peptides are worse, and the handling practice that follows from it.","2026-08-22",1787473952615]